Recombinant human granulocyte colony-stimulating factor (rhG-CSF) is widely used in
healthy donors for collection of peripheral blood progenitor cells (PBPCs) for allogeneic …

Summary rhG-CSF effects in healthy volunteers, although normally transient and self-
limiting, are now believed to be more complex and heterogeneous than previously thought …

Background and Purpose—Loss of motor function is common after stroke and leads to
significant chronic disability. Stem cells are capable of self-renewal and of differentiating into …

Granulocyte colony-stimulating factor (G-CSF), which is widely used to mobilize peripheral
blood stem cells (PBSC) from normal donors, has led to the use of PBSC as a major …

Granulocyte colony stimulating factor (G‐CSF)‐mobilized peripheral blood stem cells
(PBSC) are now widely used instead of bone marrow for autologous transplantation due to …

Human granulocyte colony-stimulating factor (G-CSF) is a granulopoietic growth factor used
in the treatment of neutropenia following chemotherapy, myeloablative treatment, or healthy …

Background Drugs that promote angiogenesis include statins, recombinant human
granulocyte colony-stimulating factor, and stromal cell-derived factor-1. Low doses of …

BACKGROUND: Allogeneic peripheral blood progenitor cell (PBPC) transplantation
requires granulocyte–colony‐stimulating factor (G‐CSF) administration to mobilize PBPCs in …

The potential application for stem cell therapy is vast, and development for use in ischaemic
stroke is still in its infancy. Access to stem cells for research is contentious; however, stem …

The harvesting of peripheral blood progenitor cells (PBPCs) after granulocyte colony-
stimulating factor or granulocyte-macrophage colony-stimulating factor stimulation instead of …